TY - JOUR
T1 - Human papillomavirus vaccination guideline update
T2 - American Cancer Society guideline endorsement
AU - on behalf of the American Cancer Society Guideline Development Group
AU - Saslow, Debbie
AU - Andrews, Kimberly S.
AU - Manassaram-Baptiste, Deana
AU - Loomer, Lacey
AU - Lam, Kristina E.
AU - Fisher-Borne, Marcie
AU - Smith, Robert A.
AU - Fontham, Elizabeth T.H.
N1 - Publisher Copyright:
© 2016 American Cancer Society
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Answer questions and earn CME/CNE. The American Cancer Society (ACS) reviewed and updated its guideline on human papillomavirus (HPV) vaccination based on a methodologic and content review of the Advisory Committee on Immunization Practices (ACIP) HPV vaccination recommendations. A literature review was performed to supplement the evidence considered by the ACIP and to address new vaccine formulations and recommendations as well as new data on population outcomes since publication of the 2007 ACS guideline. The ACS Guideline Development Group determined that the evidence supports ACS endorsement of the ACIP recommendations, with one qualifying statement related to late vaccination. The ACS recommends vaccination of all children at ages 11 and 12 years to protect against HPV infections that lead to several cancers and precancers. Late vaccination for those not vaccinated at the recommended ages should be completed as soon as possible, and individuals should be informed that vaccination may not be effective at older ages. CA Cancer J Clin 2016;66:375–385.
AB - Answer questions and earn CME/CNE. The American Cancer Society (ACS) reviewed and updated its guideline on human papillomavirus (HPV) vaccination based on a methodologic and content review of the Advisory Committee on Immunization Practices (ACIP) HPV vaccination recommendations. A literature review was performed to supplement the evidence considered by the ACIP and to address new vaccine formulations and recommendations as well as new data on population outcomes since publication of the 2007 ACS guideline. The ACS Guideline Development Group determined that the evidence supports ACS endorsement of the ACIP recommendations, with one qualifying statement related to late vaccination. The ACS recommends vaccination of all children at ages 11 and 12 years to protect against HPV infections that lead to several cancers and precancers. Late vaccination for those not vaccinated at the recommended ages should be completed as soon as possible, and individuals should be informed that vaccination may not be effective at older ages. CA Cancer J Clin 2016;66:375–385.
KW - Advisory Committee on Immunization Practices
KW - American Cancer Society
KW - cancer prevention
KW - guideline
KW - human papillomavirus (HPV)
KW - vaccine
UR - http://www.scopus.com/inward/record.url?scp=84985929995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84985929995&partnerID=8YFLogxK
U2 - 10.3322/caac.21355
DO - 10.3322/caac.21355
M3 - Review article
C2 - 27434803
AN - SCOPUS:84985929995
SN - 0007-9235
VL - 66
SP - 375
EP - 385
JO - CA Cancer Journal for Clinicians
JF - CA Cancer Journal for Clinicians
IS - 5
ER -